Supplements to clean arteries — the claim is everywhere online. But which ones actually have clinical evidence, which are dangerous hype, and which carry real drug interaction risks? As an integrative cardiologist, Dr. Regina Druz evaluates arterial supplements not just on whether they move lipid numbers, but on whether they address the mechanisms that drive plaque: oxidative stress, inflammation, endothelial dysfunction, and metabolic dysfunction.

This guide gives you the honest clinical breakdown — mechanism, evidence tier, dosing, and what to watch out for.

Can Supplements Actually Clean Your Arteries?

No supplement dissolves or removes existing arterial plaque. What the best-studied supplements can do is meaningfully different — and still clinically valuable: reduce LDL oxidation (the form of LDL that triggers plaque formation), lower inflammation driving plaque progression, improve endothelial function (the artery’s inner lining), reduce LDL and triglycerides through specific mechanisms, and in some cases slow measurable atherosclerosis progression on imaging.

The distinction matters because misleading marketing around “artery cleansing” sets unrealistic expectations and sometimes leads people to delay necessary medical care. Supplements work best as part of a comprehensive cardiovascular strategy — not as a substitute for addressing the metabolic root causes of atherosclerosis.

Supplements to Clean Arteries: Evidence Tiers

Not all supplements are equal. The following are rated by the strength and consistency of clinical evidence:

Strong evidence — multiple independent randomized controlled trials with consistent results and meaningful effect sizes.
Moderate evidence — smaller or fewer RCTs, or trials with inconsistent results, but a plausible mechanism and reasonable clinical support.
Weak evidence — limited, conflicting, or low-quality trials; theoretical mechanisms without robust human outcomes data.

Strong Evidence

1. Omega-3 Fatty Acids (EPA and DHA)

Omega-3 fatty acids are the most extensively studied cardiovascular supplement with the strongest outcomes data. EPA and DHA — found in fish oil — reduce triglycerides by 20–50% at therapeutic doses, lower inflammatory markers including hsCRP and IL-6, reduce platelet aggregation, and improve endothelial function. The landmark REDUCE-IT trial found that high-dose EPA (4g/day of icosapentaenoic acid) reduced major cardiovascular events by 25% in high-risk patients on statins. Standard fish oil at 1–2g/day provides modest benefits; therapeutic cardiovascular doses are 2–4g/day of combined EPA+DHA. Quality matters — look for products with third-party testing for oxidation and heavy metals. Prescription-strength omega-3s (Vascepa, Lovaza) are available for patients with severe hypertriglyceridemia.

2. Vitamin K2 (MK-7 form)

Vitamin K2 is one of the most underappreciated supplements in cardiovascular medicine. It activates Matrix Gla Protein (MGP), which prevents calcium from depositing in arterial walls — a key component of plaque hardening and vascular stiffening. Studies show that higher vitamin K2 intake is associated with reduced coronary artery calcification and lower cardiovascular mortality. The Rotterdam Study found that participants with the highest K2 intake had a 52% lower risk of severe aortic calcification. The MK-7 form has the longest half-life and best evidence for arterial protection. Standard dose: 90–180 mcg daily. Patients on warfarin must consult their physician before supplementing.

Moderate Evidence

3. Berberine

Berberine is a plant alkaloid that works through multiple cardiovascular mechanisms simultaneously. It inhibits PCSK9 — the same protein targeted by the most potent prescription cholesterol drugs — increasing LDL receptor expression and clearance. It activates AMPK, improving insulin sensitivity and reducing hepatic cholesterol synthesis. Meta-analyses of randomized trials show berberine reduces LDL by approximately 18–25 mg/dL, triglycerides by 15–20 mg/dL, and fasting glucose by 15–20 mg/dL. This makes it particularly valuable for patients whose elevated LDL is driven by insulin resistance rather than genetics. Critical caveat: berberine inhibits CYP3A4 and P-glycoprotein, which can significantly elevate plasma levels of statins (especially simvastatin and lovastatin), cyclosporine, and certain antihypertensives. A formal drug interaction review is mandatory before use. Dose: 500mg twice daily with meals.

For a deeper evidence review of berberine alongside aged garlic and bergamot, Dr. Druz has compiled a full clinical dossier available in Holistic Heart University: Aged Garlic, Berberine, or Bergamot.

4. Aged Garlic Extract

Raw garlic and aged garlic extract (AGE) differ significantly in their clinical profile. AGE — produced through a cold-aging process that converts harsh compounds into stable S-allylcysteine (SAC) — has demonstrated specific benefits for arterial health. Multiple randomized trials show AGE reduces coronary artery calcium progression, lowers blood pressure by 5–8 mmHg, reduces LDL oxidation, and favorably modifies gut microbiome composition with downstream effects on bile acid metabolism. A 2016 study published in the Journal of Nutrition found AGE slowed CAC progression by 1.5 times compared to placebo in patients with metabolic syndrome. Standard dose: 600–1,200mg daily. Precaution: AGE inhibits platelet aggregation — discuss with your physician if you are on anticoagulants. Discontinue 10 days before elective surgery.

The full clinical profile of aged garlic extract, including dosing protocols and the CAC trial data, is covered in the Holistic Heart University: Aged Garlic, Berberine, or Bergamot e-book.

5. Coenzyme Q10 (CoQ10)

CoQ10 is an endogenous antioxidant critical for mitochondrial energy production in heart muscle. It protects LDL from oxidation — a key step in atherosclerotic plaque initiation. Statins deplete CoQ10 by inhibiting the same pathway that produces both cholesterol and CoQ10 (the mevalonate pathway), which is the primary reason for statin-associated muscle symptoms. CoQ10 supplementation in statin-treated patients has shown improvements in endothelial function and reductions in oxidative stress markers. A meta-analysis found CoQ10 reduced systolic blood pressure by approximately 11 mmHg and diastolic by 7 mmHg. Standard dose: 100–400mg daily; the ubiquinol form has superior absorption. Particularly recommended for statin users and patients over 50.

6. Citrus Bergamot

Citrus bergamot extract, derived from a citrus fruit grown in Calabria, Italy, has emerged as one of the most promising natural cholesterol-modifying agents. Its unique flavonoids — neoeriocitrin, neohesperidin, and naringin — activate AMPK and inhibit HMG-CoA reductase (the same enzyme statins target). Meta-analyses report LDL reductions of 35–55 mg/dL, total cholesterol reductions of 50–65 mg/dL, triglyceride reductions of 50–75 mg/dL, and meaningful HDL increases. Critically, bergamot also reduces small dense LDL — the most atherogenic lipoprotein fraction — which many lipid-lowering agents do not address. A 2021 RCT found bergamot phytosome reduced visceral fat alongside lipid improvements. Dose: 500–1,000mg daily. No significant drug interactions identified to date.

The mechanism, dosing protocols, and trial comparisons for bergamot are covered in detail in the Holistic Heart University: Aged Garlic, Berberine, or Bergamot e-book.

Weak Evidence

7. Nattokinase

Nattokinase is an enzyme derived from natto (fermented soybeans) with fibrinolytic properties — it breaks down fibrin, a protein involved in blood clot formation. Several small clinical trials have shown nattokinase reduces carotid intima-media thickness (a direct measure of arterial disease) and improves blood viscosity. A 2009 randomized trial found nattokinase significantly reduced carotid IMT after 26 weeks compared to placebo.

However, nattokinase is classified here as weak evidence because the existing trials are small, short-duration, and lack hard cardiovascular outcomes data. The mechanism is plausible but not yet validated at the scale required to draw firm clinical conclusions. It addresses thrombotic rather than atherogenic aspects of cardiovascular risk — a meaningful but different mechanism from the supplements above. Dose: 2,000–4,000 FU (fibrinolytic units) daily. Important: nattokinase has significant anticoagulant activity — it cannot be combined with warfarin, aspirin, clopidogrel, or other blood thinners without physician oversight.

For a full review of the nattokinase trial data, mechanisms, and clinical use cases, see the Holistic Heart University: Nattokinase Clinical Dossier.

Supplements That Are Overhyped for Arterial Health

Several supplements are heavily marketed for “artery cleaning” without meaningful clinical evidence:

Chelation therapy supplements (oral EDTA): oral EDTA is not absorbed in meaningful amounts; only IV chelation under medical supervision has been studied (and that evidence is contested). Oral chelation products are not effective.

High-dose niacin: Despite raising HDL significantly, clinical trials failed to show reduced cardiovascular events over statin therapy alone, and it carries significant side effect burden. Not recommended as a routine supplement.

Policosanol: Early Cuban studies showed promise, but independent replication has been largely negative. The evidence doesn’t support its use for arterial health.

The Integrative Cardiologist’s Approach to Supplement Selection

At Holistic Heart Centers, supplement selection is driven by testing — not guesswork. The markers that determine which supplements are most relevant include: LDL particle number and small dense LDL (NMR LipoProfile), oxidized LDL, hsCRP and other inflammatory markers, Lp(a), fasting insulin and HOMA-IR, intracellular CoQ10 levels, omega-3 index, and coronary artery calcium score for direct plaque burden assessment.

A patient with insulin-resistance-driven dyslipidemia gets a different protocol than one with genetically elevated Lp(a) or elevated oxidized LDL. The right supplement for arterial health is the one matched to the mechanism driving your specific risk — which requires more than a standard annual lipid panel to identify.

Want to know which supplements are right for your specific arterial health picture? A Step 1 Explore visit with Dr. Druz includes advanced lipid testing, inflammatory markers, and a personalized supplement protocol built around your actual cardiovascular biology. Schedule a free strategy call →

Frequently Asked Questions

What supplements to clean arteries are most effective?

The supplements with the strongest clinical evidence for arterial health are high-dose omega-3 fatty acids (EPA) and vitamin K2 MK-7. Moderate evidence supports berberine (for metabolic dysfunction), aged garlic extract, CoQ10 (especially for statin users), and citrus bergamot for lipid lowering. Nattokinase has early promising data but remains weak evidence pending larger trials. No single supplement is universally best — the right choice depends on the specific mechanism driving your arterial risk.

Are supplements to unclog arteries safe?

The most important safety considerations involve drug interactions. Berberine significantly affects CYP3A4 and can elevate statin levels. Nattokinase and aged garlic extract have anticoagulant activity that can potentiate blood thinners. Vitamin K2 requires consultation for patients on warfarin. None of these supplements should be started without reviewing your current medication list with your physician.

How long do supplements take to affect arterial health?

Lipid changes from berberine, bergamot, and omega-3s are typically visible on a repeat panel within 6–8 weeks. Reductions in inflammatory markers like hsCRP may take 2–3 months. Changes in coronary artery calcium — a direct measure of plaque — require 12–24 months of consistent intervention to detect on imaging. Testing at 4–6 weeks is generally too early to draw conclusions about efficacy.

Can supplements replace statins?

For patients with established cardiovascular disease, diabetes, or a 10-year cardiovascular risk above 7.5%, statins have decades of outcomes data demonstrating reduced heart attack and stroke rates that supplements cannot match. For patients with mildly elevated cholesterol, no established disease, and a preference for non-pharmacologic approaches, supplements alongside dietary changes represent a reasonable first step under medical supervision.

What supplements interact with statins?

Berberine is the most important interaction — it inhibits CYP3A4, the enzyme that metabolizes simvastatin and lovastatin, potentially doubling or tripling their plasma levels and raising myopathy risk. Red yeast rice (which contains naturally occurring lovastatin) should not be combined with prescription statins. CoQ10 and bergamot are generally safe with statins. Always review your complete medication list with your prescribing physician before adding any supplement.

This article was reviewed by Dr. Regina Druz, MD, MBA, FACC, FASNC — Board-Certified Integrative Cardiologist at Holistic Heart Centers, Roslyn, NY.

References:

  1. Bhatt DL, et al. Cardiovascular Risk Reduction with Icosapentaenoic Acid for Hypertriglyceridemia (REDUCE-IT). N Engl J Med. 2019;380(1):11-22.
  2. Geleijnse JM, et al. Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease. J Nutr. 2004;134(11):3100-3105.
  3. Blais JE, et al. Overall and Sex-Specific Effect of Berberine for Treatment of Dyslipidemia. Drugs. 2023;83(5):455-476.
  4. Budoff MJ, et al. Inhibiting Progression of Coronary Calcification Using Aged Garlic Extract. Prev Med. 2009;49(2-3):218-223.
  5. Rosenfeldt FL, et al. Coenzyme Q10 in the Treatment of Hypertension: A Meta-Analysis. J Hum Hypertens. 2007;21(4):297-306.
  6. Toth PP, et al. Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis. Front Pharmacol. 2016;6:299.
  7. Kim JY, et al. Effects of Nattokinase on Blood Pressure: A Randomized Controlled Trial. Hypertens Res. 2008;31(8):1583-1588.